111 – 120 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden--an evolutionary advantage?
- Contribution to journal › Letter
-
Mark
No increased risk of venous thrombosis in women taking tranexamic acid
- Contribution to journal › Letter
-
Mark
Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man
- Contribution to journal › Article
-
Mark
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism : Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls
- Contribution to journal › Article
- 2000
-
Mark
Impact, diagnosis and treatment of von Willebrand disease
- Contribution to journal › Article
- 1999
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
- Contribution to journal › Article
-
Mark
Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents
- Contribution to journal › Article
-
Mark
Prophylactic infusion regimens in the management of hemophilia
- Contribution to journal › Article
-
Mark
The Ala25-Thr mutation in the thrombomodulin gene is not frequent in Swedish patients suffering from ischemic heart disease [9]
- Contribution to journal › Letter
-
Mark
Control of smooth muscle cell proliferation - The role of the basement membrane
- Contribution to journal › Article
